HDIM
CHE icon

Hanson & Doremus Investment Management’s Chemed CHE Stock Holding History

Hanson & Doremus Investment Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Sell
3,065
-32
-1% -$13.5K 0.15% 82
2026
Q1 		$1.17M Sell
3,097
-40
-1% -$17.1K 0.13% 88
2025
Q4 		$1.34M Sell
3,137
-17
-0.5% -$7.4K 0.16% 75
2025
Q3 		$1.41M Buy
3,154
+3
+0.1% +$1.36K 0.18% 71
2025
Q2 		$1.53M Sell
3,151
-342
-10% -$195K 0.21% 68
2025
Q1 		$2.15M Buy
3,493
+437
+14% +$248K 0.31% 54
2024
Q4 		$1.62M Sell
3,056
-78
-2% -$44K 0.25% 59
2024
Q3 		$1.88M Sell
3,134
-29
-0.9% -$16.4K 0.3% 54
2024
Q2 		$1.72M Sell
3,163
-92
-3% -$52.7K 0.29% 57
2024
Q1 		$2.09M Sell
3,255
-7
-0.2% -$4.25K 0.36% 51
2023
Q4 		$1.91M Sell
3,262
-37
-1% -$20.7K 0.36% 54
2023
Q3 		$1.71M Sell
3,299
-36
-1% -$18.7K 0.35% 59
2023
Q2 		$1.81M Sell
3,335
-238
-7% -$130K 0.38% 57
2023
Q1 		$1.92M Sell
3,573
-627
-15% -$320K 0.43% 52
2022
Q4 		$2.14M Buy
4,200
+614
+17% +$299K 0.46% 51
2022
Q3 		$1.57M Sell
3,586
-20
-0.6% -$9.62K 0.4% 56
2022
Q2 		$1.69M Sell
3,606
-290
-7% -$141K 0.41% 50
2022
Q1 		$1.97M Sell
3,896
-25
-0.6% -$12K 0.42% 46
2021
Q4 		$2.07M Buy
3,921
+3
+0.1% +$1.44K 0.44% 43
2021
Q3 		$1.82M Sell
3,918
-243
-6% -$115K 0.42% 47
2021
Q2 		$2M Sell
4,161
-544
-12% -$261K 0.6% 31
2021
Q1 		$2.16M Sell
4,705
-65
-1% -$31.9K 0.5% 43
2020
Q4 		$2.54M Buy
4,770
+609
+15% +$299K 0.63% 29
2020
Q3 		$2M Sell
4,161
-375
-8% -$184K 0.6% 31
2020
Q2 		$2.05M Sell
4,536
-856
-16% -$382K 0.65% 27
2020
Q1 		$2.34M Buy
5,392
+71
+1% +$31.7K 0.79% 25
2019
Q4 		$2.34M Sell
5,321
-71
-1% -$29.9K 0.67% 32
2019
Q3 		$2.25M Sell
5,392
-651
-11% -$266K 0.7% 28
2019
Q2 		$2.18M Sell
6,043
-217
-3% -$72.5K 0.69% 32
2019
Q1 		$2M Sell
6,260
-226
-3% -$69.4K 0.66% 32
2018
Q4 		$1.84M Sell
6,486
-375
-5% -$113K 0.66% 32
2018
Q3 		$2.19M Sell
6,861
-96
-1% -$30.6K 0.69% 31
2018
Q2 		$2.24M Sell
6,957
-1,059
-13% -$331K 0.74% 27
2018
Q1 		$2.19M Buy
8,016
+690
+9% +$183K 0.68% 37
2017
Q4 		$1.78M Sell
7,326
-136
-2% -$30.9K 0.59% 43
2017
Q3 		$1.51M Sell
7,462
-14
-0.2% -$2.75K 0.53% 52
2017
Q2 		$1.53M Sell
7,476
-160
-2% -$31.9K 0.57% 50
2017
Q1 		$1.4M Sell
7,636
-499
-6% -$87K 0.56% 51
2016
Q4 		$1.3M Sell
8,135
-85
-1% -$12.5K 0.56% 49
2016
Q3 		$1.16M Sell
8,220
-175
-2% -$24.4K 0.54% 55
2016
Q2 		$1.14M Sell
8,395
-60
-0.7% -$7.96K 0.52% 56
2016
Q1 		$1.15M Sell
8,455
-380
-4% -$51.4K 0.52% 54
2015
Q4 		$1.32M Sell
8,835
-315
-3% -$46.5K 0.6% 46
2015
Q3 		$1.22M Sell
9,150
-235
-3% -$32.9K 0.59% 50
2015
Q2 		$1.23M Sell
9,385
-370
-4% -$45.8K 0.52% 57
2015
Q1 		$1.17M Sell
9,755
-450
-4% -$50K 0.49% 61
2014
Q4 		$1.08M Sell
10,205
-600
-6% -$63.4K 0.46% 65
2014
Q3 		$1.11M Sell
10,805
-100
-0.9% -$10.1K 0.5% 63
2014
Q2 		$1.02M Hold
10,905
– – 0.47% 65
2014
Q1 		$976K Sell
10,905
-100
-0.9% -$8.15K 0.46% 69
2013
Q4 		$843K Sell
11,005
-3,900
-26% -$288K 0.4% 77
2013
Q3 		$1.07M Buy
14,905
+320
+2% +$22.8K 0.54% 59
2013
Q2 		$1.06M Buy
+14,585
New +$1.07M 0.58% 54

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Hanson & Doremus Investment Management's CHE Position: Q2 2026 in Review

Hanson & Doremus Investment Management reduced its Chemed (CHE) stake by 1% in Q2 2026, selling an estimated $13.5K and leaving 3,065 shares worth $1.43M. The position accounts for 0.15% of the portfolio, ranked #82.

Hanson & Doremus Investment Management first reported a position in CHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.54M in Q4 2020. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Hanson & Doremus Investment Management held 3,065 shares of Chemed worth $1.43M as of Q2 2026.
  • Hanson & Doremus Investment Management sold 32 Chemed shares in Q2 2026, an estimated $13.5K.
  • Chemed made up 0.15% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #82 holding.
  • Hanson & Doremus Investment Management first reported a position in Chemed in Q2 2013 and has held it in 53 quarters since.
  • Hanson & Doremus Investment Management's Chemed position peaked at $2.54M in Q4 2020.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.